[Clinical importance of determination of antigens of cancerous origin].
D000510:Alpha-Globulins / Q000032:analysis; D000951:Antigens, Neoplasm / Q000032:analysis*; D001798:Blood Proteins / Q000032:analysis; D001943:Breast Neoplasms / Q000175:diagnosis; D002364:Caseins / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D005260:Female; D005326:Fetal Proteins / Q000032:analysis; D005770:Gastrointestinal Neoplasms / Q000175:diagnosis; D006023:Glycoproteins / Q000032:analysis; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis; D008297:Male; D009362:Neoplasm Metastasis / Q000175:diagnosis; D009369:Neoplasms / Q000097:blood / Q000175:diagnosis*
D000510:Alpha-Globulins; D000951:Antigens, Neoplasm; D001798:Blood Proteins; D002364:Caseins; D006063:Chorionic Gonadotropin; D005326:Fetal Proteins; D006023:Glycoproteins
Intérêt clinique du dosage d'antigènes d'origine cancéreuse